Dexcel Pharma is a finished-dose manufacturer based in Israel. It appears in 92 regulatory filings across 8 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, MHRA (UK) and MPA (SE). Its GMP standing is certified by ZLG (DE), NAFDAC (NG) and EMA.
| Site | FDA FEI |
|---|---|
| Bavaria, Germany | Not on file |
| Alzenau, Germany | Not on file |
| Southern Industrial Zone or Akiva, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EMA | 40 | 1 |
| MHRA (UK) | 31 | None |
| MPA (SE) | 8 | None |
| US FDA | 5 | None |
| INFARMED (PT) | 3 | None |
| AIFA (IT) | 3 | None |
| ZLG (DE) | None | 4 |
| NAFDAC (NG) | None | 2 |
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Dexcel Pharma comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.